Oligonucleotide Synthesis Market Report 2026

Oligonucleotide Synthesis Market Overview

• Oligonucleotide Synthesis market size has reached to $11.92 billion in 2025 • Expected to grow to $26.08 billion in 2030 at a compound annual growth rate (CAGR) of 17.1% • Growth Driver: The Oligonucleotide Synthesis Market Set To Expand With The Rising Prevalence Of Chronic Diseases • Market Trend: Ansa Biotechnologies Launches Precision DNA Solutions With Clonal DNA And DNA Fragments • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Oligonucleotide Synthesis Market?

Oligonucleotide synthesis is the chemical linking of nucleotides, precisely forming the desired sequenced product. This process is helpful in modern laboratory practice as it offers quick and affordable access to oligonucleotides manufactured to order with the necessary sequence. The main types of oligonucleotide synthesis are custom oligos and predesigned oligos. Custom oligos are oligonucleotides made by solid-phase chemical synthesis, in which the four nucleic acids A, T, C, and G are added to form a chain of nucleotides. The several types of products are involved, such as oligonucleotides, reagents, equipment, services, purification, and modification, which are used in various applications, including therapeutic applications, research applications, and diagnostic applications.

What Is The Oligonucleotide Synthesis Market Growth Forecast?

The oligonucleotide synthesis market size is expected to see rapid growth in the next few years. It will grow to $26.08 billion in 2030 at a compound annual growth rate (CAGR) of 17.1%. The growth in the forecast period can be attributed to growing demand from therapeutic and diagnostic applications, increasing adoption of automated synthesis platforms, advancements in gene therapy research, rising investment in biotechnology research, expansion of oligo-based research and diagnostics globally. Major trends in the forecast period include advancements in gene editing and personalized medicine, integration of cloud-based data management platforms, application of ai for sequence optimization and design, automation in oligonucleotide synthesis processes, iot-enabled equipment monitoring and process tracking.

Global Oligonucleotide Synthesis Market Segmentation

1) By Type: Custom Oligos, Predesigned Oligos 2) By Solution Type: Oligonucleotides, Reagents, Equipment, Services, Purification, Modification 3) By Application: Therapeutic Applications, Research Applications, Diagnostic Applications Subsegments: 1) By Custom Oligos: Long Oligonucleotides, Short Oligonucleotides, Modified Oligonucleotides 2) By Predesigned Oligos: Gene-Specific Oligos, Probe Oligos, Primers For PCR And RT-PCR

What Is The Driver Of The Oligonucleotide Synthesis Market?

The rising prevalence of chronic diseases is expected to propel the growth of the oligonucleotide synthesis market going forward. Chronic diseases refer to conditions that last one year or longer and require continuous medical attention, which may worsen over time. Oligonucleotides, via various mechanisms, act on gene expression that causes chronic diseases. They can target mRNA, pre-mRNA, or non-coding RNA to modulate splicing events, induce degradation, or interfere with protein translation. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the rising prevalence of chronic and rare diseases is driving the growth of the oligonucleotide synthesis industry.

Key Players In The Global Oligonucleotide Synthesis Market

Major companies operating in the oligonucleotide synthesis market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE HealthCare Technologies Inc., Eurofins Scientific SE, Agilent Technologies Inc., Nitto Denko Avecia Inc., Alnylam Pharmaceuticals Inc., Maravai Life Sciences, LGC Limited, Ionis Pharmaceuticals Inc., GenScript Inc., Ajinomoto Bio-Pharma Services, Sarepta Therapeutics Inc., Integrated DNA Technologies Inc., Twist Bioscience Corporation, Eurogentec SA, Kaneka Eurogentec S.A., Biocomma Limited, Bio-Synthesis Inc., TriLink BioTechnologies Incorporated, Generi Biotech s.r.o., ATDBio Ltd., BioAutomation Corporation, Biolegio B.V., Dharmacon Research Inc.

Global Oligonucleotide Synthesis Market Trends and Insights

Major companies operating in the oligonucleotide synthesis market are focusing on developing innovative DNA products to enhance sequence accuracy, simplify workflows, and support advanced research applications. For instance, in July 2024, Ansa Biotechnologies, Inc., a US-based company specializing in complex DNA manufacturing, launched Ansa Clonal DNA and Ansa DNA Fragments. Ansa Clonal DNA provides clonal, sequence-perfect DNA up to 600 base pairs in length, eliminating the need for assembly and offering unmatched accuracy for complex synthetic biology projects. This product ensures error-free, ready-to-use DNA sequences, making it a reliable choice for researchers. Ansa DNA Fragments offers sequence-verified linear double-stranded DNA fragments, also up to 600 base pairs, tailored for diverse research applications. With its innovative enzymatic synthesis process, Ansa reliably produces complex DNA constructs, including repeats and secondary structures, with high precision.

What Are Latest Mergers And Acquisitions In The Oligonucleotide Synthesis Market?

In June 2024, GSK plc, a UK-based pharmaceutical company, acquired Elsie Biotechnologies for $ 50 million. The acquisition allows GSK to fully integrate Elsie’s oligonucleotide discovery, synthesis, and delivery technologies into its research and development framework. This integration is expected to enhance GSK's existing capabilities in developing oligonucleotide-based medicines. Elsie Biotechnologies is a US-based company specializing in oligonucleotide therapeutics.

Regional Outlook

North America was the largest region in the oligonucleotide synthesis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Oligonucleotide Synthesis Market?

The oligonucleotide synthesis market consists of revenues earned by entities by providing non-coding RNA inhibition, splicing modulation, gene activation, and programmed gene editing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The oligonucleotide synthesis market also includes sales of RNAi oligonucleotides, antisense oligonucleotides, condensation activators, sulfur-transfer reagents, and deprotection reagents. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Oligonucleotide Synthesis Market Report 2026?

The oligonucleotide synthesis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the oligonucleotide synthesis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.